Wilcox I, Grunstein R R, Hedner J A, Doyle J, Collins F L, Fletcher P J, Kelly D T, Sullivan C E
Department of Medicine, University of Sydney, Australia.
Sleep. 1993 Sep;16(6):539-44. doi: 10.1093/sleep/16.6.539.
Ambulatory blood pressure (BP) was measured noninvasively (Oxford Medilog ABP) at 15-minute intervals for 24 hours before and after 8 weeks of treatment with nasal continuous positive airway pressure (nCPAP) in 19 men with obstructive sleep apnea (OSA). We included both normotensive and hypertensive patients, but hypertensives were studied after withdrawal of antihypertensive drugs. Ambulatory BP before and after treatment was compared using patients as their own controls. Treatment with nCPAP was successfully established in 14 of the 19 patients (74%). Blood pressure fell significantly in patients who were successfully treated: 24-hour mean BP (systolic/diastolic) decreased from 141 +/- 18/89 +/- 11 mm Hg to 134 +/- 19/85 +/- 13 mm Hg (p < 0.05). The reduction in 24-hour mean systolic BP occurred during both day and night, but a significant fall in mean diastolic BP was only observed during the day. The mean blood pressure fell in both normotensive and hypertensive patients. Patients who were inadequately treated with nCPAP had no reduction in mean 24-hour BP. Effective treatment of sleep apnea with nCPAP was associated with a significant fall in both systolic and diastolic BP independent of changes in body weight or alcohol consumption, suggesting that sleep apnea was an independent factor contributing to elevated nighttime and daytime BP in these patients.
对19名阻塞性睡眠呼吸暂停(OSA)男性患者,在接受鼻腔持续气道正压通气(nCPAP)治疗8周前后,通过无创方式(牛津Medilog动态血压监测仪)每隔15分钟测量一次动态血压,共测量24小时。我们纳入了血压正常和高血压患者,但高血压患者在停用降压药后进行研究。以患者自身作为对照,比较治疗前后的动态血压。19名患者中有14名(74%)成功建立了nCPAP治疗。成功治疗的患者血压显著下降:24小时平均血压(收缩压/舒张压)从141±18/89±11毫米汞柱降至134±19/85±13毫米汞柱(p<0.05)。24小时平均收缩压在白天和夜间均下降,但平均舒张压仅在白天显著下降。血压正常和高血压患者的平均血压均下降。nCPAP治疗效果不佳的患者24小时平均血压没有降低。nCPAP有效治疗睡眠呼吸暂停与收缩压和舒张压显著下降相关,且与体重或酒精摄入量的变化无关,这表明睡眠呼吸暂停是导致这些患者夜间和白天血压升高的独立因素。